Arginase and pulmonary diseases

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 378, Issue 2, 2008, Pages 171-184

  Maarsingh, Harm ^a   Pera, Tonio ^a   Meurs, Herman ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Arginase; Asthma; Chronic obstructive pulmonary disease; Cystic fibrosis; Nitric oxide; Pulmonary hypertension

Indexed keywords

ARGINASE; ARGININE; CONSTITUTIVE NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; PEROXYNITRITE; STAT6 PROTEIN; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; UREA;

ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; LUNG DISEASE; PATHOGENESIS; PROTEIN FUNCTION; PULMONARY HYPERTENSION; REVIEW; TH2 CELL;

ANIMALS; ARGINASE; ARGININE; ASTHMA; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION, PULMONARY; LUNG; LUNG DISEASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; UREA;

EID: 47149110024     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-008-0286-7     Document Type: Review

References (137)

1. Abe M, Hayashi Y, Murai A, Shibata K, Sakata N, Igarashi R, Katsuragi T, Tanaka K (2006) Effects of inducible nitric oxide synthase inhibitors on asthma depending on administration schedule. Free Radic Biol Med 40:1083-1095
2. Agusti AG, Villaverde JM, Togores B, Bosch M (1999) Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. Eur Respir J 14:523-528
3. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, Stamler JS (1994) Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA 91:10089-10093
4. Atz AM, Wessel DL (1997) Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol 21:441-455
5. Barnes PJ (1998) Nitric oxide. In: Barnes PJ, Rodger IW, Thompson NC (eds) Asthma: basic mechanism and clinical management. 3rd edn. Academic Press, London, pp 369-388
6. Barnes PJ, Shapiro SD, Pauwels RA (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22:672-688
7. Belik J, Shehnaz D, Pan J, Grasemann H (2008) Developmental changes in arginase expression and activity in the lung. Am J Physiol Lung Cell Mol Physiol
8. Bergeron C, Boulet LP, Page N, Laviolette M, Zimmermann N, Rothenberg ME, Hamid Q (2007) Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J Allergy Clin Immunol 119:391-397
9. Bhowmik A, Seemungal TA, Donaldson GC, Wedzicha JA (2005) Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Eur Respir J 26:1009-1015
10. Boucher JL, Custot J, Vadon S, Delaforge M, Lepoivre M, Tenu JP, Yapo A, Mansuy D (1994) N-Omega-Hydroxy-l-Arginine, an intermediate in the l-Arginine to Nitric-Oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem Biophys Res Commun 203:1614-1621
11. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM (2000) Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161:1720-1745
12. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA (2005) Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 26:52-59
13. Chachaj W, Gladysz A, Puchala-Liebhart E, Wrzyszcz, Ostrowska E (1978) Carbamoyl ornithine transferase, arginase and cobalt-activated acylase in patients during asthma attacks or patients with respiratory failure. Pol Tyg Lek 33:85-88
14. Cirino G, Fiorucci S, Sessa WC (2003) Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol Sci 24:91-95
15. Ckless K, Van der Vliet A, Janssen-Heininger Y (2007) Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism. Am J Respir Cell Mol Biol 36:645-653
16. Cook S, Vollenweider P, Menard B, Egli M, Nicod P, Scherrer U (2003) Increased eNO and pulmonary iNOS expression in eNOS null mice. Eur Respir J 21:770-773
17. Corraliza IM, Soler G, Eichmann K, Modolell M (1995) Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun 206:667-673
18. Daghigh F, Fukuto JM, Ash DE (1994) Inhibition of rat liver arginase by an intermediate in NO biosynthesis, NG-hydroxy-l-arginine: implications for the regulation of nitric oxide biosynthesis by arginase. Biochem Biophys Res Commun 202:174-180
19. De Boer J, Meurs H, Coers W, Koopal M, Bottone AE, Visser AC, Timens W, Zaagsma J (1996) Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study. Br J Pharmacol 119:1109-1116
20. De Boer J, Duyvendak M, Schuurman FE, Pouw FM, Zaagsma J, Meurs H (1999) Role of l-arginine in the deficiency of nitric oxide and airway hyperreactivity after the allergen-induced early asthmatic reaction in guinea-pigs. Br J Pharmacol 128:1114-1120
21. De Boer J, Meurs H, Flendrig L, Koopal M, Zaagsma J (2001) Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs. Br J Pharmacol 133:1235-1242
22. De Gouw HW, Grunberg K, Schot R, Kroes AC, Dick EC, Sterk PJ (1998) Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 11:126-132
23. Downey D, Elborn JS (2000) Nitric oxide, iNOS, and inflammation in cystic fibrosis. J Pathol 190:115-116
24. Elphick HE, Demoncheaux EA, Ritson S, Higenbottam TW, Everard ML (2001) Exhaled nitric oxide is reduced in infants with cystic fibrosis. Thorax 56:151-152
25. Endo M, Oyadomari S, Terasaki Y, Takeya M, Suga M, Mori M, Gotoh T (2003) Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell Mol Physiol 285:L313-L321
26. Erdely A, Kepka-Lenhart D, Clark M, Zeidler-Erdely P, Poljakovic M, Calhoun WJ, Morris Jr SM (2006) Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages. Am J Physiol Lung Cell Mol Physiol 290:L534-L539
27. Fajardo I, Svensson L, Bucht A, Pejler G (2004) Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med 170:477-484
28. Flak TA, Goldman WE (1996) Autotoxicity of nitric oxide in airway disease. Am J Respir Crit Care Med 154:S202-S206
29. Gaston B, Ratjen F, Vaughan JW, Malhotra NR, Canady RG, Snyder AH, Hunt JF, Gaertig S, Goldberg JB (2002) Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med 165:387-390
30. Gebel S, Gerstmayer B, Kuhl P, Borlak J, Meurrens K, Muller T (2006) The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression. Toxicol Sci 93:422-431
31. Grasemann H, Michler E, Wallot M, Ratjen F (1997) Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 24:173-177
32. Grasemann H, Ioannidis I, Tomkiewicz RP, de GH, Rubin BK, Ratjen F (1998) Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 78:49-53
33. Grasemann H, Knauer N, Buscher R, Hubner K, Drazen JM, Ratjen F (2000) Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 162:2172-2176
34. Grasemann H, Storm van's Gravesande K, Gartig S, Kirsch M, Buscher R, Drazen JM, Ratjen F (2002) Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism. Nitric Oxide 6:236-241
35. Grasemann H, Storm van's Gravesande K, Buscher R, Knauer N, Silverman ES, Palmer LJ, Drazen JM, Ratjen F (2003) Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med 167:390-394
36. Grasemann H, Grasemann C, Kurtz F, Tietze-Schillings G, Vester U, Ratjen F (2005a) Oral l-arginine supplementation in cystic fibrosis patients: a placebo-controlled study. Eur Respir J 25:62-68
37. Grasemann H, Schwiertz R, Matthiesen S, Racke K, Ratjen F (2005b) Increased Arginase Activity in Cystic Fibrosis Airways. Am J Respir Crit Care Med 1523-1528
38. Grasemann H, Kurtz F, Ratjen F (2006a) Inhaled l-arginine Improves Exhaled Nitric Oxide and Pulmonary Function in Cystic Fibrosis Patients. Am J Respir Crit Care Med 174:208-212
39. Grasemann H, Schwiertz R, Grasemann C, Vester U, Racke K, Ratjen F (2006b) Decreased systemic bioavailability of l-arginine in patients with cystic fibrosis. Respir Res 7:87
40. Gray MJ, Poljakovic M, Kepka-Lenhart D, Morris SM Jr. (2005) Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene 353:98-106
41. Greene AL, Rutherford MS, Regal RR, Flickinger GH, Hendrickson JA, Giulivi C, Mohrman ME, Fraser DG, Regal JF (2005) Arginase activity differs with allergen in the effector phase of ovalbumin-versus trimellitic anhydride-induced asthma. Toxicol Sci 88:420-433
42. Gross TJ, Hunninghake GW (2001) Idiopathic pulmonary fibrosis. N Engl J Med 345:517-525
43. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, Polak JM (1993) Induction of nitric oxide synthase in asthma. Lancet 342:1510-1513
44. Hays SR, Ferrando RE, Carter R, Wong HH, Woodruff PG (2005) Structural changes to airway smooth muscle in cystic fibrosis. Thorax 60:226-228
45. Hey C, Boucher JL, Vadon-Le Goff S, Ketterer G, Wessler I, Racké K (1997) Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on l-arginine utilization by nitric oxide synthase. Br J Pharmacol 121:395-400
46. Hilliard TN, Regamey N, Shute JK, Nicholson AG, Alton EW, Bush A, Davies JC (2007) Airway remodelling in children with cystic fibrosis. Thorax 62:1074-1080
47. Hobbs CA, Gilmour SK (2000) High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. J Cell Biochem 77:345-360
48. Hoet PH, Nemery B (2000) Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions. Am J Physiol Lung Cell Mol Physiol 278:L417-L433
49. Hogg JC (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364:709-721
50. Hoyt JC, Robbins RA, Habib M, Springall DR, Buttery LD, Polak JM, Barnes PJ (2003) Cigarette smoke decreases inducible nitric oxide synthase in lung epithelial cells. Exp Lung Res 29:17-28
51. Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, Diwan BA, Schimel DM, Cochard AE, Wang X, Schechter AN, Noguchi CT, Gladwin MT (2007) Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 109:3088-3098
52. Hutchison SJ, Sievers RE, Zhu BQ, Sun YP, Stewart DJ, Parmley WW, Chatterjee K (2001) Secondhand tobacco smoke impairs rabbit pulmonary artery endothelium-dependent relaxation. Chest 120:2004-2012
53. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K (2000) Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 162:701-706
54. Imamura M, Waseda Y, Marinova GV, Ishibashi T, Obayashi S, Sasaki A, Nagai A, Azuma H (2007) Alterations of NOS, arginase, and DDAH protein expression in rabbit cavernous tissue after administration of cigarette smoke extract. Am J Physiol Regul Integr Comp Physiol 293:R2081-R2089
55. Ito K, Caramori G, Lim S, Oates T, Chung KF, Barnes PJ, Adcock IM (2002) Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med 166:392-396
56. Jeffery PK (2000) Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. Chest 117:251S-260S
57. Jenkinson CP, Grody WW, Cederbaum SD (1996) Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 114:107-132
58. Kaneko FT, Arroliga AC, Dweik RA, Comhair SA, Laskowski D, Oppedisano R, Thomassen MJ, Erzurum SC (1998) Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med 158:917-923
59. Kharitonov SA, Barnes PJ (2001) Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163:1693-1722
60. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ (1994) Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135
61. Kharitonov S, O'connor BJ, Evans DJ, Barnes PJ (1995a) Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 151:1894-1897
62. Kharitonov SA, Robbins RA, Yates D, Keatings V, Barnes PJ (1995b) Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 152:609-612
63. Kitowska K, Zakrzewicz D, Konigshoff M, Chrobak I, Grimminger F, Seeger W, Bulau P, Eickelberg O (2008) Functional Role and Species-specific Contribution of Arginases in Pulmonary Fibrosis. Am J Physiol Lung Cell Mol Physiol 294:L34-L45
64. Klasen S, Hammermann R, Fuhrmann M, Lindemann D, Beck KF, Pfeilschifter J, Racke K (2001) Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol 132:1349-1357
65. Kochanski L, Kossmann S, Rogala E, Dwornicki J (1980) Sputum arginase activity in bronchial asthma. Pneumonol Pol 48:329-332
66. Kuo HP, Liu S, Barnes PJ (1992) The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways. Eur J Pharmacol 221:385-388
67. Kurosawa M, Shimizu Y, Tsukagoshi H, Ueki M (1992) Elevated levels of peripheral-blood, naturally occurring aliphatic polyamines in bronchial asthmatic patients with active symptoms. Allergy 47:638-643
68. Lewis CC, Yang JY, Huang X, Banerjee SK, Blackburn MR, Baluk P, McDonald DM, Blackwell TS, Nagabhushanam V, Peters W, Voehringer D, Erle DJ (2007) Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med 177:376-387
69. Li H, Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Estela DR-N, Kistner EO, Gjessing HK, Lara-Sanchez IC, Chiu GY, London SJ (2006) Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J Allergy Clin Immunol 117:119-126
70. Lindemann D, Racke K (2003) Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 368:546-550
71. Maarsingh H, Bossenga BB, Bos IST, Zaagsma J, Meurs H (2004) Arginase-and polycation-induced l-arginine limitation causes deficiency of bronchodilating NO and airway hyperreactivity after the late asthmatic reaction. Eur Respir J 24[Suppl 48]:681s
72. Maarsingh H, Tio MA, Zaagsma J, Meurs H (2005) Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation. Respir Res 6:23
73. Maarsingh H, Leusink J, Bos IST, Zaagsma J, Meurs H (2006) Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res 7:6
74. Marshall HE, Stamler JS (2001) Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40:1688-1693
75. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ (1998) Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:998-1002
76. Mehta S, Drazen JM, Lilly CM (1997) Endogenous nitric oxide and allergic bronchial hyperresponsiveness in guinea pigs. Am J Physiol 273:L656-L662
77. Meurs H, Hamer MA, Pethe S, Vadon-Le Goff S, Boucher JL, Zaagsma J (2000) Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity. Br J Pharmacol 130:1793-1798
78. Meurs H, McKay S, Maarsingh H, Hamer MA, Macic L, Molendijk N, Zaagsma J (2002) Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 136:391-398
79. Meurs H, Maarsingh H, Zaagsma J (2003) Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 24:450-455
80. Mhanna MJ, Ferkol T, Martin RJ, Dreshaj IA, Van Heeckeren AM, Kelley TJ, Haxhiu MA (2001) Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice. Am J Respir Cell Mol Biol 24:621-626
81. Misson P, Van den Brûle S, Barbarin V, Lison D, Huaux F (2004) Markers of macrophage differentiation in experimental silicosis. J Leukoc Biol 76:926-932
82. Modolell M, Corraliza IM, Link F, Soler G, Eichmann K (1995) Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 25:1101-1104
83. Moncada S, Palmer RM, Higgs EA (1989) Biosynthesis of nitric oxide from l-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38:1709-1715
84. Mora AL, Torres-Gonzalez E, Rojas M, Corredor C, Ritzenthaler J, Xu J, Roman J, Brigham K, Stecenko A (2006) Activation of alveolar macrophages via the alternative pathway in herpes virus-induced lung fibrosis. Am J Respir Cell Mol Biol 35:466-473
85. Morris CR, Morris SM, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP (2003) Arginine therapy- A new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 168:63-69
86. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM Jr (2004) Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 170:148-153
87. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294:81-90
88. Muijsers RB, Van Ark I, Folkerts G, Koster AS, Van Oosterhout AJ, Postma DS, Nijkamp FP (2001) Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice. Br J Pharmacol 134:434-440
89. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, Fuentes JM, Luckner C, Doschko G, Soler G, Eichmann K, Muller FM, Ho AD, Goerner M, Modolell M (2005) Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105:2549-2556
90. Nelin LD, Krenz GS, Chicoine LG, Dawson CA, Schapira RM (2002) L-Arginine uptake and metabolism following in vivo silica exposure in rat lungs. Am J Respir Cell Mol Biol 26:348-355
91. Nelin LD, Chicoine LG, Reber KM, English BK, Young TL, Liu Y (2005) Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptor. Am J Respir Cell Mol Biol 33:394-401
92. Olson JW (1985) Chronic cigarette sidestream smoke exposure increases rat trachea ornithine decarboxylase activity. Life Sci 37:2165-2171
93. Olson JW, Crooks PA (1985) Effect of nicotine and N'-nitrosonornicotine on rat lung and trachea ornithine decarboxylase activity. Carcinogenesis 6:1517-1519
94. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:1256-1276
95. Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A, Scott N, Summar ML (2001) Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 344:1832-1838
96. Poljakovic M, Porter DW, Millecchia L, Kepka-Lenhart D, Beighley C, Wolfarth MG, Castranova V, Morris SM Jr (2007) Cell-and isoform-specific increases in arginase expression in acute silica-induced pulmonary inflammation. J Toxicol Environ Health A 70:118-127
97. Postma DS, Kerstjens HA (1998) Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158:S187-S192
98. Que LG, Kantrow SP, Jenkinson CP, Piantadosi CA, Huang YC (1998) Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol 275:L96-102
99. Renkema TE, Postma DS, Noordhoek JA, Sluiter HJ, Kauffman HF (1991) In vitro release of neutrophil elastase, myeloperoxidase and beta-glucuronidase in patients with emphysema and healthy subjects. Eur Respir J 4:1237-1244
100. Ricciardolo FLM (2003) Multiple roles of nitric oxide in the airways. Thorax 58:175-182
101. Ricciardolo FLM, DiMaria GU, Mistretta A, Sapienza MA, Geppetti P (1997) Impairment of bronchoprotection by nitric oxide in severe asthma. Lancet 350:1297-1298
102. Ricciardolo FL, Timmers MC, Geppetti P, Van Schadewijk A, Brahim JJ, Sont JK, De Gouw HW, Hiemstra PS, Van Krieken JH, Sterk PJ (2001) Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J Allergy Clin Immunol 108:198-204
103. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G (2004) Nitric oxide in health and disease of the respiratory system. Physiol Rev 84:731-765
104. Ricciardolo FL, Zaagsma J, Meurs H (2005) The therapeutic potential of drugs targeting the arginase pathway in asthma. Expert Opin Investig Drugs 14:1221-1231
105. Robbins RA, Hadeli K, Nelson D, Sato E, Hoyt JC (2000) Nitric oxide, peroxynitrite, and lower respiratory tract inflammation. Immunopharmacology 48:217-221
106. Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, Murray PJ (2001) Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol 166:2173-2177
107. Sadeghi-Hashjin G, Folkerts G, Henricks PAJ, Verheyen AKCP, Van der Linde HJ, Van Ark I, Coene A, Nijkamp FP (1996) Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 153:1697-1701
108. Sadeghi-Hashjin G, Folkerts G, Henricks PAJ, Muijsers RBR, Nijkamp FP (1998) Peroxynitrite in airway diseases. Clin Exp Allergy 28:1464-1473
109. Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A (1998) Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 12:929-937
110. Samb A, Pretolani M, Dinh-Xuan AT, Ouksel H, Callebert J, Lisdero C, Aubier M, Boczkowski J (2001) Decreased pulmonary and tracheal smooth muscle expression and activity of type 1 nitric oxide synthase (nNOS) after ovalbumin immunization and multiple aerosol challenge in guinea pigs. Am J Respir Crit Care Med 164:149-154
111. Sandler NG, Mentink-Kane MM, Cheever AW, Wynn TA (2003) Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol 171:3655-3667
112. Sasaki A, Doi S, Mizutani S, Azuma H (2007) Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats. Am J Physiol Lung Cell Mol Physiol 292:L1480-L1487
113. Satriano J (2004) Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids 26:321-329
114. Schapira RM, Wiessner JH, Morrisey JF, Almagro UA, Nelin LD (1998) l-arginine uptake and metabolism by lung macrophages and neutrophils following intratracheal instillation of silica in vivo. Am J Respir Cell Mol Biol 19:308-315
115. Schuiling M, Meurs H, Zuidhof AB, Venema N, Zaagsma J (1998a) Dual action of iNOS-derived nitric oxide in allergen-induced airway hyperreactivity in conscious, unrestrained guinea pigs. Am J Respir Crit Care Med 158:1442-1449
116. Schuiling M, Zuidhof AB, Bonouvrie MA, Venema N, Zaagsma J, Meurs H (1998b) Role of nitric oxide in the development and partial reversal of allergen-induced airway hyperreactivity in conscious, unrestrained guinea-pigs. Br J Pharmacol 123:1450-1456
117. Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS (2006) Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 36:1575-1583
118. Shearer JD, Richards JR, Mills CD, Caldwell MD (1997) Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol 272:E181-E190
119. Sutherland ER, Martin RJ (2003) Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol 112:819-827
120. Tadie JM, Henno P, Leroy I, Danel C, Naline E, Faisy C, Riquet M, Levy M, Israel-Biet D, Delclaux C (2008) Role of the nitric oxide synthase/arginase balance on bronchial reactivity in patients with chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 294:L489- L497
121. Takemoto K, Shibamori M, Hitomi Y, Takigawa T, Wang DH, Ichimura H, Fujikura Y, Ogino K (2007) Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am J Physiol Lung Cell Mol Physiol 293:L1419-L1426
122. Ten Broeke R, De CR, Van Haperen R, Verweij V, Leusink-Muis T, Van Ark I, De Clerck F, Nijkamp FP, Folkerts G (2006) Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir Res 7:58
123. Thomassen MJ, Buhrow LT, Connors MJ, Kaneko FT, Erzurum SC, Kavuru MS (1997) Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 17:279-283
124. Thyberg J, Fredholm BB (1987a) Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth-muscle cells stimulated with platelet-derived growth-factor. Exp Cell Res 170:160-169
125. Thyberg J, Fredholm BB (1987b) Modulation of arterial smooth-muscle cells from contractile to synthetic phenotype requires induction of ornithine decarboxylase activity and polyamine synthesis. Exp Cell Res 170:153-159
126. Tiddens HA, De Jong PA (2007) Imaging and clinical trials in cystic fibrosis. Proc Am Thorac Soc 4:343-346
127. Wang WW, Jenkinson CP, Griscavage JM, Kern RM, Arabolos NS, Byrns RE, Cederbaum SD, Ignarro LJ (1995) Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 210:1009-1016
128. Wei LH, Jacobs AT, Morris SM Jr, Ignarro LJ (2000) IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol 279:C248-C256
129. Wei LH, Wu G, Morris SM Jr, Ignarro LJ (2001) Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci USA 98:9260-9264
130. Wu G, Morris SM (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336:1-17
131. Xia Y, Zweier JL (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94:6954-6958
132. Xia Y, Roman LJ, Masters BS, Zweier JL (1998) Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem 273:22635-22639
133. Xu W, Kaneko FT, Zheng S, Comhair SA, Janocha AJ, Goggans T, Thunnissen FB, Farver C, Hazen SL, Jennings C, Dweik RA, Arroliga AC, Erzurum SC (2004) Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 18:1746-1748
134. Yan ZQ, Hanson GK, Skoogh BE, Lotvall JO (1995) Induction of nitric oxide synthase in a model of allergic occupational asthma. Allergy 50:760-764
135. Yang M, Rangasamy D, Matthaei KI, Frew AJ, Zimmmermann N, Mahalingam S, Webb DC, Tremethick DJ, Thompson PJ, Hogan SP, Rothenberg ME, Cowden WB, Foster PS (2006) Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol 177:5595-5603
136. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, Muntel EE, Witte DP, Pegg AA, Foster PS, Hamid Q, Rothenberg ME (2003) Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 111:1863-1874
137. Zuyderduyn S, Ninabar DK, Fens N, Maarsingh H, Meurs H, Sterk PJ, Hiemstra PS, Rabe KF (2006) IL-4 enhances arginase-2 expression in human airway smooth muscle cells (HASM). Proc Am Thoracic Soc 3:A462